Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) FCF Margin (2012 - 2026)

Updated

Kamada (KMDA) reported FCF Margin of 36.73% for the quarter ended Jun 30, 2026, up 14.31 percentage points from 22.42% a year earlier and up 35.23 percentage points from the prior quarter.

Analysis

Kamada (KMDA) FCF Margin (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kamada's FCF Margin came in at 23.56%, down 5.14 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 19.58%, down 16.66 percentage points from the prior year.

  • FCF Margin has a five-year change of +1.12 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, FCF Margin came in at 36.24% in the year ended Dec 31, 2024 (+29.11 pp), 7.13% in the year ended Dec 31, 2023 (-17.89 pp), 25.03% in the year ended Dec 31, 2022 (+29.94 pp) and -4.91% in the year ended Dec 31, 2021 (-23.37 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly FCF Margin since the quarter ended Sep 30, 2024.
  • Year over year, FCF Margin gained in three of the last eight quarters, with an average year-over-year change of +1.53 percentage points.
  • The high point for year-over-year FCF Margin in five years was the quarter ended Jun 30, 2022 (a gain of 57.06 percentage points); the low point was the quarter ended Dec 31, 2021 (a drop of 60.55 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 1.51% (quarter ended Mar 31, 2026), 23.15% (quarter ended Dec 31, 2025) and 29.79% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 36.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.73%
Mar 31, 2026 1.51%
Dec 31, 2025 23.15%
Sep 30, 2025 29.79%
Jun 30, 2025 22.42%
Mar 31, 2025 2.17%
Dec 31, 2024 34.15%
Sep 30, 2024 58.31%
Jun 30, 2024 39.96%
Mar 31, 2024 9.81%
Dec 31, 2023 22.19%
Sep 30, 2023 6.99%
Jun 30, 2023 7.61%
Mar 31, 2023 -5.65%
Dec 31, 2022 16.99%
Sep 30, 2022 22.06%
Jun 30, 2022 49.03%
Mar 31, 2022 21.28%
Dec 31, 2021 -13.43%
Sep 30, 2021 -4.99%
API Access

Kamada FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY